T. Rowe Price Credit Opportunities Fund (PRCPX)
Ticker Symbol:
PRCPX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 01/31/2017
Volatility and Other Measures
as of 01/31/2017
Beta N/A
N/A
Standard Deviation N/A
Credit Quality Diversification1
as of 01/31/2017
% of Total Net Assets
BBB/BB Rated & Above 3.1%
BB Rated 12.0%
BB/B Rated 13.5%
B Rated 28.9%
B/CCC Rated 12.6%
CCC and Below 13.3%
Credit Default Swaps -0.1%
Default 0.6%
Equities 2.6%
Not Rated 0.6%
Short Term 12.8%
1Sources: Moody's Investors Service and Standard & Poor's (S&P); split ratings (e.g., BB/B and B/CCC) are assigned when the Moody's and S&P ratings differ. T. Rowe Price does not evaluate these ratings, but simply assigns them to the appropriate credit quality category as determined by the rating agency. Short-term holdings are not rated.

Short term holdings are not rated.
Weighted Avg. Duration
as of 01/31/2017
2.22 years
Weighted Avg. Maturity
as of 02/21/2017
4.84 years
Sector Diversification
as of 01/31/2017
% of Total Net Assets
Defensive 42.1%
Cyclical 34.5%
Short-Term 12.8%
Energy 10.6%
10 Largest Holdings
View Holdings as of:
Coupon % Maturity
ALTICE SA 144A 7.625 02/15/2025
ASURION LLC TL 2L BANKDEBT 8.500 03/03/2021
AVOLON HOLDINGS LTD TL B2 1L BANKDEBT 3.500 01/20/2022
CLEAR CHNL COMMS TL D-EXT 1L BANKDEBT 7.528 01/30/2019
INTELSAT JACKSON HLDG 144A 8.000 02/15/2024
KRONOS INC/MA TL B 1L BANKDEBT 5.000 11/01/2023
PACIFIC EXPLORATION AND 10.000 11/02/2021
TERRA-GEN POWER TL B 1L BANKDEBT 5.250 12/09/2021
UBER TECHNOLOGIES INC TL B 1L BANKDEBT 5.000 07/13/2023
VALEANT PHARMACEUTICALS 144A 7.000 10/01/2020
As of 01/31/2017 the Credit Opportunities Fund had a total of 171 holdings.
Bond Maturity Diversification2
  as of 01/31/2017
% of Total Net Assets
0 - 1 YRS 13.2%
1 - 5 YRS 34.6%
5 - 10 YRS 51.6%
10 + YRS 0.6%
2Total may not equal 100% due to rounding.
See Glossary for additional details on all data elements.